91 related articles for article (PubMed ID: 16725145)
21. CD36 signaling inhibits the translation of heat shock protein 70 induced by oxidized low density lipoprotein through activation of peroxisome proliferators-activated receptor gamma.
Lee KJ; Ha ES; Kim MK; Lee SH; Suh JS; Lee SH; Park KH; Park JH; Kim DJ; Kang D; Kim BC; Jeoung D; Kim YK; Kim HD; Hahn JH
Exp Mol Med; 2008 Dec; 40(6):658-68. PubMed ID: 19116451
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
[TBL] [Abstract][Full Text] [Related]
23. Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.
Kim SH; Yoo CI; Kim HT; Park JY; Kwon CH; Kim YK
Toxicol Appl Pharmacol; 2006 Sep; 215(2):198-207. PubMed ID: 16616945
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
[TBL] [Abstract][Full Text] [Related]
25. Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones.
Dewar BJ; Gardner OS; Chen CS; Earp HS; Samet JM; Graves LM
Mol Pharmacol; 2007 Nov; 72(5):1146-56. PubMed ID: 17686966
[TBL] [Abstract][Full Text] [Related]
26. Opposite effects of two thiazolidinediones, ciglitazone and troglitazone, on proteinase-activated receptor-1-triggered prostaglandin E(2) release.
Takaoka K; Sekiguchi F; Shigi H; Maeda Y; Nishikawa H; Kawabata A
Toxicology; 2010 Jan; 268(1-2):40-5. PubMed ID: 19954759
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
Hamaguchi E; Takamura T; Shimizu A; Nagai Y
J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
[TBL] [Abstract][Full Text] [Related]
28. Troglitazone inhibits endothelial cell proliferation through suppression of casein kinase 2 activity.
Lee KS; Park JH; Lee S; Lim HJ; Jang Y; Park HY
Biochem Biophys Res Commun; 2006 Jul; 346(1):83-8. PubMed ID: 16759638
[TBL] [Abstract][Full Text] [Related]
29. Troglitazone's rapid and sustained activation of ERK1/2 induces cellular acidosis in LLC-PK1-F+ cells: physiological responses.
Oliver R; Friday E; Turturro F; Lacy A; Welbourne T
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1257-66. PubMed ID: 15687249
[TBL] [Abstract][Full Text] [Related]
30. Troglitazone, a ligand of peroxisome proliferator-activated receptor-{gamma}, stabilizes NUCB2 (Nesfatin) mRNA by activating the ERK1/2 pathway: isolation and characterization of the human NUCB2 gene.
Yamada M; Horiguchi K; Umezawa R; Hashimoto K; Satoh T; Ozawa A; Shibusawa N; Monden T; Okada S; Shimizu H; Mori M
Endocrinology; 2010 Jun; 151(6):2494-503. PubMed ID: 20427483
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells.
Soller M; Dröse S; Brandt U; Brüne B; von Knethen A
Mol Pharmacol; 2007 Jun; 71(6):1535-44. PubMed ID: 17325128
[TBL] [Abstract][Full Text] [Related]
32. Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g.
Lee KJ; Kim HA; Kim PH; Lee HS; Ma KR; Park JH; Kim DJ; Hahn JH
Exp Mol Med; 2004 Dec; 36(6):534-44. PubMed ID: 15665586
[TBL] [Abstract][Full Text] [Related]
33. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.
LeBrasseur NK; Kelly M; Tsao TS; Farmer SR; Saha AK; Ruderman NB; Tomas E
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E175-81. PubMed ID: 16464908
[TBL] [Abstract][Full Text] [Related]
34. Troglitazone inhibits cyclin D1 expression and cell cycling independently of PPARgamma in normal mouse skin keratinocytes.
He G; Thuillier P; Fischer SM
J Invest Dermatol; 2004 Dec; 123(6):1110-9. PubMed ID: 15610522
[TBL] [Abstract][Full Text] [Related]
35. Effect of thiazolidinediones on bile acid transport in rat liver.
Snow KL; Moseley RH
Life Sci; 2007 Jan; 80(8):732-40. PubMed ID: 17126857
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of oxidation of low density lipoprotein by troglitazone.
Noguchi N; Sakai H; Kato Y; Tsuchiya J; Yamamoto Y; Niki E; Horikoshi H; Kodama T
Atherosclerosis; 1996 Jun; 123(1-2):227-34. PubMed ID: 8782853
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.
Miller YI; Viriyakosol S; Worrall DS; Boullier A; Butler S; Witztum JL
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1213-9. PubMed ID: 15718493
[TBL] [Abstract][Full Text] [Related]
38. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S
Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579
[TBL] [Abstract][Full Text] [Related]
39. Role of epidermal growth factor receptor (EGFR)-signaling versus cellular acidosis via Na+/H+ exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of breast cancer-derived cells MCF-7.
Friday E; Oliver R; Welbourne T; Turturro F
Cell Physiol Biochem; 2007; 20(6):751-62. PubMed ID: 17982257
[TBL] [Abstract][Full Text] [Related]
40. [Toll-like receptor 4 promotes macrophage foam cell formation induced by oxidized low-density/β₂-glycoprotein I/β₂-glycoprotein I antibodies complex].
Zhang X; Zhou H; Xu Y; Liu J; Xie H; Kong X; Xie Y; Yan J
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Mar; 42(3):208-13. PubMed ID: 24831477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
